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Background: Diabetic peripheral neuropathy (DPN) affects the lives of approximately 
50% of all persons diagnosed with diabetes. Patients who are minorities, residents of 
rural communities, low income, or non-compliant with treatment, have a higher risk of 
developing DPN. The long-term effects interfere with the patient’s abilities to carry out 
activities of daily living (ADLs) and instrumental activities of daily living (IADLs). 
Patients incur debt from medical expenses, depression from the inability to perform self- 
care, and became withdrawn because of their distorted body image. 
Purpose: The purpose of this project was to use the Michigan Neuropathy Screening 
Instrument (MNSI) scale to improve patient outcomes by promoting better identification 
of individuals who need to be referred out to a specialist. 
Design Methods: The patients were interviewed and surveyed using the Michigan 
Neuropathy Screening Instrument (MNSI). After using the MNSI tool, patients were 
evaluated for possible referral to podiatry and vascular specialty. 
Conclusion: Results demonstrated the use of the MNSI tool improves the screening 
process of patients diagnosed with diabetes reporting signs and symptoms of DPN. 
Implications for Nursing: This project has the potential to improve patient quantality of 
life, and lower cost to both patient and healthcare providers. 
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Type 2 Diabetes Mellitus (T2DM) affects over 30 million people in the United 
States of America (U.S.A.) (Jiwani et al., 2021). The strain to the healthcare system is 
costly and impacts the quality of care distributed to all patients (Levy, 2021). Providers 
are strained with the task of seeing more patients in less time. In the rush of seeing 
patients, quality measures are not being met. Yearly referrals for foot exams, vision 
screenings, and glycated hemoglobin (A1cs) check are being missed (Anastasi & Klung, 
2021). The patients are the ones who suffer from the lack of tracking their participation 
in these gold standard screenings (Anastasi & Klung, 2021). 
There is a shortage of healthcare providers, and the onboard training of new 
providers is often not inclusive of all standard protocols (Magny-Normilus et al., 
2021). Due to the recent pandemic, staff meetings have been limited and quality 
measures are not the priority. In previous years, all staff were included in quality 
measures. This method allowed everyone to be informed and active  from start to finish 
within a patient encounter. For example, medical assistants (MA) often assisted the 
provider in tracking patients annual screenings during the triage process (Anastasi & 
Klung, 2021). 
Prevention of peripheral neuropathy is an essential step in caring for the self- 
esteem in patients with T2DM (Hicks & Selvin, 2019). Foot ulcers are a risk in 25% of 
identified patients with diabetic peripheral neuropathy (DPN) (Hicks & Selvin, 2019). 
These patients are then at higher risk for lower limb amputations, foot ulcers, chronic 
pain, and an increase in mortality. The decline in motor function causes a decrease in 
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self-esteem and ability to complete activities of daily living (ADLs) (Parasoglou, Rao & 
Slade, 2017). The effects of DPN causes impaired balance in majority of all patients 
(Kukidome et al., 2017). In rural healthcare settings, transportation and financial 
hardships can limit the number of times healthcare providers encounter their patients 
diagnosed with diabetes. 
Research has shown screening tools used specifically for DPN assist in achieving 
better outcomes (Hershey, 2017). The purpose of this project was to use the scale to 
improve patient outcomes by promoting better identification of individuals who need to 
be referred out to a specialist (Fateh, Madani, Heshmat, & Larijani,2016). 
Background 
 
If one was able to prevent T2DM, then the complications, in turn, are also 
prevented (Hoogendoorn et al.,2021). In this case, diabetic peripheral neuropathy (DPN) 
was the focused complication. Studies have shown there are clinical implications prior to 
the final diagnosis. Healthcare facilities would benefit from a system used to screen and 
provide assess for early signs of DPN. This diagnosis results in increased cost for 
patients, a decrease in their independence, and a decrease in patient self-esteem 
(Hoogendoorn et al., 2021). 
In a 2020 publication by Ahary, the researcher found compliance in T2DM 
management was low, especially in women (Ahrary, 2020). Patients often suffer from 
preventable complications of this disease. The responsibility of education and 
implementation of early prevention lies in the hands of the healthcare team. When 
patients were asked in routine visits of their last podiatric or visual screening, they were 
unaware of the need.  The observation of this lack of awareness of their basic care needs 
raised a red flag.  The increase of communication assisted patients of both genders with 
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diabetic compliance (Ahrary, 2020). 
This DNP project was implemented to assist the rural community in early 
detection of DPN (Levy, 2021). Studies show living in rural communities, belonging to a 
minority group, or living below the poverty line, increase your mortality rate. This 
project  was conducted in two separate private practices. Each practice was enthusiastic 
to participate in a quality improvement project which could result in better patient 
outcomes. Both healthcare clinics had a high prevalence of diabetic patients with the 
need of preventative care. Individuals in the participant group ranged from newly 
diagnosed patients to those with very advanced cases of T2DM. Staff explored the 
importance of early detection at a primary care level. Patients were assessed for this 
project during regularly scheduled appointments. Levy (2021) suggested implementing a 
screening into the normal triage process that would benefit both the patient and 
healthcare quality measures. 
Insurance providers hold insurers to a high standard of care (Chicharro-Luna et 
al., 2020). Many organizations are reimbursed based on the percentage of quality 
measures completed. Foot screening and diabetic eyes exams are a part of the quality 
measures. Ensuring patients are compliant with each of these not only benefits the 
patient, but increases financial reimbursement for the organization. This was not the sole 
reason for this project, but it did offer an incentive (Chicharro-Luna et al.,2020). 
The goal of this study was to maximize each patient encounter for individuals 
with a diagnosis of T2DM in order to actively assist in maximizing their quality of life. 
Research has shown providers should maximize contact time with each appointment 
(Levy, 2021). This process did not inconvenience the participants, while still providing 
them an improvement in care.  
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A study by Bauer et al., (2018) took into careful consideration a plan to 
implement strategies to increase self-esteem in patients diagnosed with T2DM. Patients 
identified as being diagnosed with T2DM were screened using the Michigan Neuropathy 
Screening Instrument (see Appendix A) (MNSI, 2000). 
Problem Statement 
 
There is a need to identify and screen for diabetic peripheral neuropathy in 
diabetic patient populations in rural healthcare settings. For this project, a needs 
assessment revealed there was no protocol in place to identify DPN in patients on 
scheduled visits. Facilities current practices resulted in providers treating signs and 
symptoms as the patient brought it to their attention. Patients reported being unsatisfied 
with their providers efforts to prevent future DPN complications.  This project focused on 
creating a screening policy for each patient with T2DM using the Michigan Neuropathy 
Screening Instrument, the integration of this screening tool will encourage 
patient/provider discussion which should result in earlier treatment (MNSI, 2000). 
Obstacles that one encountered included provider and patient openness to change. 
Transportation to and from scheduled appointments also proved difficult for indigent 
patients. One project goal was to minimize the increase in patient triage times and one-
on-one time with providers due to screening. 
The PICO format is used to articulate questions to assist in Evidence Based 
Practice (EBP) (Evidence Based Medicine, 2021). Using the PICO model helped outline 
all elements deemed essential in this project. The model aided team members to support 
the project presented. In rural patients previously diagnosed with diabetes mellitus (P) 
how does being screened for diabetic peripheral neuropathy using the Michigan 
Neuropathy  Screening Instrument (MNSI) (I) compared to the same patients (C) prior to 
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        screening, when addressing the rate of detection of peripheral neuropathy (O) 
 
(Evidence Based Medicine,2021). 
 
Organizational Description of Project Site 
 
The project was conducted at two privately owned healthcare practice locations. 
 
The two locations were rural practices where each provider sees on average 30 to 40 
patients daily, respectively. The population consisted of patients diagnosed with diabetes, 
hypertension, chronic pain, pulmonology, and peripheral neuropathy. The patient 




Review of the Literature 
 
The databases used most in this research were Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), PubMed, and BioMed Central. The search was 
limited to scholarly articles published within the past five years. The following terms 
which produced the most beneficial articles were DPN, diabetic foot ulcers, diabetic 
vascular complications, and diabetic complications. 
Hicks and Selvin (2019) conducted a quantitative study focused on the impact of 
DPN and found that 50% of patients suffering with DPN will continue to develop further 
complications. DPN cannot be reversed, and providers’ goal was to prevent and treat. The 
authors found patient outcomes increased when patients maintained a desirable weight, 
patient e education, increased physical activity, foot care, and pain control (Hicks & 
Selvin, 2019). 
The American Diabetes Association (ADA) recommended early prevention and 
screening of DPN due to their review of cross-sectional data (Hicks &Selvin, 2019). 
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Ahrary, Khosravan, Alami, and Nesheli, (2020) conducted an individual randomized 
controlled trial focusing on the effects of diabetic education in women. Hicks and Selvin 
(2019) found patient education was an important preventative method in treating DPN. 
Ahrary et al. (2020) comprised two trial groups totaling 115 participants. The trial group 
(N=60) was given one-month close interventions with consistent in-person education 
specific and appropriate for the group’s DPN diagnosis (Ahrary et al., 2020). There was a 
significant decrease in the reporting of symptoms related to DPN. 
Baurer et al. (2018) used increased technology to improve patient symptoms 
related to DPN. The study randomized patients over six months to take part in a usual 
care (UC) test. Patient demographics were balanced (N=62; 53% female, mean age = 63 
years, 94% type 2 diabetes). Patients included in the test group reported increase in pain 
threshold (Baurer et al., 2018). Text messaging was the chosen method of 
communication and support to the patients identified. The text messages increased self- 
care and education of T2DM for the patients (Baurer et al., 2018). 
Hershey (2017) explored the comfort levels of clinical providers in recognizing 
DPN in diabetic patients. The MNSI tool was used to explore its usefulness and accuracy 
in screening patients. Using the MNSI tool helped identify asymptomatic patients with 
DPN. Patients who were not identified early as suffering from DPN orT2DM were more 
likely to have amputations. The article showed how important continuing education is for 
all healthcare staff. 
Hoogendoorn et al. (2020) shared similar ideology with Luciani et al. (2021) that 
self-care improves the outcomes of those diagnoses with DPN. The exploration of 
income, educational level, and personal determination helped predict the progression of 
the disease process (Iqbal, 2018). Patients who were willing to learn proper dietary 
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requirements and measure their blood glucose levels were successful in a team approach 
treatment plan. Having a basic knowledge of reportable signs and symptoms assists 
providers in an outpatient care setting (Iqbal, 2018). Both articles agreed more studies are 
needed relating to selfcare and responsibility. 
Rodriguez et al. (2021) and Joo and Liu (2021) both took an interest in race as it 
relates to T2DM. The data generated from these studies supports the hypothesis that 
minorities are affected at a disproportionally higher rate than others. Unlike Rodriguez et 
al. (2021), Joo and Liu (2021) believed in tailoring learning tools around the culture of 
the audience being educated. Tools that include culturally considerate material are proven 
to result in higher rates of acceptance (Joo & Liu, 2021). DPN caused progressive nerve 
damage which results in amputations in some patients. Patients may also experience pain 
and paresthesia    (Hershey, 2017). The tool can be used in all patients at high risk for nerve 
damage. 
Hershey (2017) investigated depression, amputation risk, sleep disturbances, and 
chronic pain patients often report to their providers. The MNSI was the gold standard    for 
early detection. The tool had two parts. There was a questionnaire and exam to be 
performed during this proposal. The patient’s history was assessed with 15 questions that 
was answered using ‘yes’ or ‘no’ (Hershey, 2017). The examination was conducted by 
examining: (a) appearance (b)ulceration (c) ankle reflexes (d) vibration sensation at the 
great toe, and (e) monofilament exam (Hershey, 2017). For purposes of this DNP project, 
only the questionnaire was used for data collection for ethical considerations for the 
patients. 
As part of their routine exam, the assessment was also completed but was not 
used for data collection in the project.  
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Evidence-Based Practice: Verification of Chosen Option 
 
The MNSI is considered the gold standard for early detection of DPN (Hershey, 
2017). The tool has two parts involving a questionnaire and exam to be performed during 
this proposal. For purposes of this DNP project, only the questionnaire was used for data 
collection for ethical considerations for the patients. As part of their routine exam, the 




Theoretical Framework/Evidence-Based Practice Model 
 
The framework model utilized for this project was the Iowa model (Cullen et al., 
2019). This model was developed by members of the Iowa University system and allows 
for practitioners to bridge the gap between research and practice using an evidence-based 
approach. An organized project design is needed to assist one in furthering the nursing 
profession. 
The model provides practitioners with a method of project development and 
implementation and utilizes a template to guide researchers from the start to finish on 
their project (Cullen et al., 2019). Identifying problem-focused or knowledge-focused 
triggers is step one of using the model. In the case of this project, the PICO is 
categorized as ‘Process Improvement Data’. The need to identify early signs and 
symptoms of DPN is important to prevent costly outcomes for patients and the 
healthcare system (Cullen et al., 2019). 
Topics not categorized as priority are not recommended per the Iowa model 
(Cullen et al., 2019). The model encourages the writer to confront more challenging 
topics. Once the topic is formed, a team is organized. One is encouraged to formulate a 
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team in which each participant can contribute to the outcome of the project. A team 
should encompass personnel of all skill sets and educational levels. Staff employed 
individuals in different positions have perspectives which can benefit the results of the 
study (Cullen et al., 2019). 
Literature is reviewed to find out if the project is supported by research (Cullen et 
al., 2019). If one uses the Iowa model, it allows early identification of a project that is not 
well researched. Without this template, one would waste valuable time on a project that 
would not yield results. Time is important when addressing quality improvement tasks. 
The project will then move into the implementation stage (Cullen et al., 2019). 
 
After careful organization of the data, the decision to apply the data should be 
made by the team (Cullen et al., 2019). The leadership team will monitor the project 
from start to finish, while ensuring to review feedback of the participants and staff. 
There are often barriers that cannot be predicted during the planning process. If the 
project is to be repeated, correcting errors each time will allow for smoother execution. 





Goals, Objectives, and Expected Outcomes 
 
The purpose of this project was to use the Michigan Neuropathy Screening 
Instrument (MNSI) scale to improve patient outcomes by promoting better identification 
of individuals who need to be referred out to a specialist. 
The goals and expected outcomes were: 
 
•  The first section of the MNSI tool will be completed on all qualifying 
patients who consent, during regularly scheduled patient appointments. 
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• There will be a goal of 12-13 MNSI exams within a 2-week period. 
 
• This implementation will occur during scheduled appointments as a 
component of the normal assessment. There was no financial incentive for 
participation.  However, the possibility for improved quality of life is the 
ultimate goal for patients. The staff at both facilities have generously 
agreed to volunteer their time. 
•  The goal of both facilities is to identify patients at high risk of 
experiencing complications of T2DM specifically related to 
DPN. 
• The MNSI tools should only add an additional 20-30 minutes to 
the patient’s total treatment time. The project data was able to 






The project design was a quality improvement (QI) project. It will assist in 
developing a health policy to detect signs of peripheral neuropathy in patients within two 
rural facilities. The QI project was a quasi-experimental design using purposive sampling 
from two clinical sites. The project consisted of short yes or no answer questions which 
will be asked verbally to patients by healthcare providers trained on the use of the tool. 
The data was used to show the percent of patients without a prior diagnosis of peripheral 
neuropathy who were identified as high risk using the MNSI scale. The screening added 
approximately five minutes to each visit. 
Project Site and Population 
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Diabetic peripheral neuropathy costs the United States (U.S.) $10.9 billion per 
year in healthcare (Hershey, 2017). DPN is typically under-reported and under- treated, 
adding a burden to an already vulnerable population (Hershey, 2017). The chosen clinical 
sites were home to an abundant number of diabetic patients who lived in rural 
communities. The sites were considered rural, due to the level of economic and 
healthcare services available. “Site A” had two medical doctors and two nurse 
practitioners. “Site B” had four vascular surgeons and one nurse practitioner. The patients 
seen daily ranged from approximately 90-120 patients collectively among providers  at 
each site. Among the patients seen, roughly 30% were diagnosed with T2DM. 
Diabetes is ranked Alabama’s ninth health concern (Alabama, 2019). During the 
project phase, the population surrounding “Site A”’ was 35,957 (U.S. Census Bureau, 
2019).  Women made up 51.1% of that population; 14.9% of the people in the area were 
age 65 and older (U.S. Census Bureau, 2019). The majority of the population’s race was 
Caucasian and made up 75.8%, while African Americans made up 18.7% (U.S. Census 
Bureau, 2019). The remaining races were a mixture of American Indian and Alaska 
Native alone, Asian alone, Native Hawaiian and Other Pacific Islander alone, Hispanic 
or Latino, and two or more races, (U.S. Census Bureau, 2019). 
The median value of owner-occupied housing was $162,700 (U.S. Census 
Bureau, 2019). There were 14,069 households, which averages out to be approximately 
2.5 people per home. The median household income was $61,110. Thirteen point one 
percent of the population were under the age of 65 with a disability, and there were 7.9% 
of individuals without health insurance under the age of 65. The poverty level was 
15.9% (U.S. Census Bureau, 2019). 
The population surrounding “Site B” was 226,486 (U.S. Census Bureau, 2019). 
12   
Women made up 53% of that population. A small percentage, 15.6%, of the people in the 
area were age 65 and older. The majority of the population’s race was White alone and 
made up 35.5%, while Black or African Americans made up 59.3%. The remaining races 
were  a mixture of American Indian and Alaska Native alone, Asian alone, Native 
Hawaiian and Other Pacific Islander alone, Hispanic or Latino and two or more races, 
(U.S. Census Bureau, 2019). 
The median value of owner-occupied housing was $129,800 (U.S. Census 
Bureau, 2019). There were 89,527 households, which averages out to be approximately 
2.46 people per home. The median household income was $50,124. A reported 11.7% of 
the population were under the age of 65 with a disability and there were 12.2% without 
health insurance under the age of 65. The poverty level was at 15.8%, (U.S. Census 
Bureau, 2019). 
Setting Facilitators and Barriers 
 
Conducting projects at two sites could have led to complications in 
implementation. Rural patients live, on average, more than 30 minutes from the two 
clinical sites used in this project. Many of the participants are transported to their routine 
appointments by a family member or close friend. This often leaves  patients feeling 
rushed. This distance often causes patients to miss their scheduled appointments. 
Patients who were illiterate may not have understood questions asked by the screeners. 
There are staff members who may have reservations of the DNP project, and see this 




The author created a PowerPoint with voiceover that explained the process of the 
study. The officer manager at each site assisted with identifying up to six staff members 
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for training. After the staff members volunteered, the training was scheduled at their 
convenience. The PowerPoint covered the complete process and allowed for questions. 
The staff members had the contact information of the project coordinators for all 
inquiries. 
           Staff members were provided a copy of steps of the implementation. The staff 
assisted primarily with gaining consent and distributing and collecting the MNSI tool. 
The providers conducted the assessment portion which completes the tool. Patients were 
educated about their right to confidentiality, privacy, and that they could opt out at any 
time  and their information would not be used. A demographic form (see appendix B) was 
also used, and data was coded. The participants were assigned a designated number. That 
number was used on the demographic form where data were collected. The patient may 
have experienced minimal distress when they learned of the need for a referral to a 
specialist depending on the findings of the survey. Confidentiality was also protected. 
Personal information was redacted from all study forms prior to data analysis. 
Participants were only identified with numbers. A form containing information linking 
names to numbers was kept on a password protected computer in the PI's office and 
will be destroyed 3 years after study completion. The project was implemented on 
November 9th, 2020 and continued until February 17th, 2021. A total of 31 
participants were interviewed. 
Measurement Instruments 
In order to measure the outcomes of this DNP project, the MNSI instrument was 
used. The MNSI tool can be found in Appendix A. This instrument was used with 
permission and it specifically addressed the peripheral neuropathy that could be 
undetected at times in the diabetic patient. 
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The MNSI has become a part of the triaging process of all patients with a 
diagnosis of T2DM. The history was completed with the nurse prior to the clinical 
provider entering the room. After the patient completed the history, the nurse helped 
remove the patient’s shoes and socks with their permission. The provider then conducted 
the physical exam on the patient as part of their routine care. If deficits were found, the 
patient was referred to the appropriate specialist to carry out additional diagnostic exams. 
Data Collection Procedures 
 
The patients entered the triage room as they typically do upon a visit. The     author 
reviewed all paperwork with participants. This ensured all guidelines were followed per 
the IRB’s standard. After informed consent was obtained, the MNSI survey was 




A professional statistician was hired to review all data produced in this project. A 
Bayesian analysis was used to analyze the data collected in this quality improvement 
project. The analysis was broken down by race, gender, age, and site locations. The 
participants were sent to podiatry and vascular specialist if the MNSI tool called for a 
more detailed look for the interest of the patient’s quality of care. The use of a statistician 
ensured the quality of the calculations of datum collected in this project. A Bayesian 
approach is appropriate for this study because it provides ratio estimates regarding two 
differing hypotheses. It is also helpful with analyzing observed data as opposed to 
unobserved quantities (Hackenberger, 2019). 
The data showed 84% of participants needed podiatry referrals and 44% required 
vascular consults. This was a key finding as diabetic patients are recommended to have 
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annual podiatric visits to increase their quality of care. The analysis reported African 
American participants were referred to a vascular specialist with a mean of 0.47 and 
standard deviation (SD) of 0.11. The Caucasian population’s vascular referral rate was 
0.44 with a SD of 0.12. This yielded a mean difference of 0.03 and showed no significant 
differences among races for vascular referrals. Podiatry referrals in African American 
participants had a mean of 0.82 with a SD of 0.09 and Caucasian participants were 0.79 
with SD of 0.10. Again, there was a mean difference 0.03 with a SD of 0.13 difference 
that s showed both races were fairly equal (see Appendix C). 
Age was another variable that was important to analyze in this project. The age of 
the participants ranged from 40-70s. Mean vascular referrals for participants in their 40s 
were reported at 0.44 with a SD of 0.17, 70-year-old participants’ mean was 0.39 with a 
SD 0.13. The mean was higher in patients in their 50- and 60-year age range. There were 
mean differences seen in podiatry referrals. There was no pattern seen related to age. The 
mean was reported above 0.50 for patients in all reported age participants (see Appendix 
D). 
Male participants needed vascular consults at a significantly higher rate than 
female participants. The mean for males was 0.64 with a SD of 0.12 and female was 
0.34 with a SD of 0.10 (see Appendix E). This is a mean difference of -0.30 and SD 
0.16. This is  a credible difference statistically. The podiatry means were high for both 
genders. The female means were 0.84 with a SD of 0.08 a mean of 0.77 for males and 
SD of 0.11 with a mean difference between genders was 0.07 with a SD of 0.13.  
Using the MNSI tool helped identify patients in need of specialty care who 
would have otherwise been overlooked. 
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Results 
 
There were two rural facilities studied in this project. The ability to compare two 
sites allowed for in depth comparison of patient type. The “Site A”’ vascular referrals 
had a mean of 0.35 and SD of 0.09; “Site B” vascular referrals had a mean of 0.75 and a 
SD of 0.13. There was a statistically significant mean difference of -0.40 with a SD of 
0.16. This  type of QI data is important, due to improvements that can be made for the 
sake of the patients. The podiatry referrals needed were high and similar at both 
facilities. “Site A”’ mean was 0.83 with a SD of 0.07, “Site B”; mean was 0.75 with a 






Some of the data yielded from this project was statistically significant. Due to 
implementing the DNP project as written, patients were able to receive real-time 
feedback. A total of 84% of participants were sent to a podiatrist and educated on yearly 
podiatric exams. Another 44% of participants showed concerning signs and symptoms 
that permitted an immediate vascular referral. The leadership team was able to gather 
pertinent feedback to assist in the future operations of their practice. 
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Male patients have a significantly higher rate of unnoticed complications of 
T2DM. It   is recommended that providers educate the staff and screen the population 
closer, to improve their quality care. The primary care practice also had a significantly 
higher rate of patients who had been overlooked for early signs and symptoms of DPN. 
This data supports the use of the MNSI tool in the primary care setting to prevent 





Clinical sites A and B did not have to operate outside of their normal office hours 
to accommodate the project. There was no cost to conduct the experiment at the two 
designated sites. The employees at “Site A” and “ Site B” volunteered their time to assist 
with the quality improvement project. Each clinical site assigned individuals who would 
be briefed to conduct the survey during the normal triaging period. Patients were not 
financially compensated but were provided screening to improve their quality of life. 
It is recommended to use the screening tools during the patients triage process. 
The tool is provided free via the internet. Quality measures require that the necessary 




The timeline for the project followed the model (Appendix G). The timeline takes 
into consideration the project due date and personnel involved. There was leniency in 
adjustments, but great effort was given to adhere to the timeline for planning phase, 
implementation phase, and data analysis phase. Consideration was given to the normal 
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operating practice of the two facilities. The project was modeled in that it could be 
implemented during regular patient visits. 
 
Ethical Considerations/Protection of Human Subjects 
 
The Jacksonville State University Institutional Review Board (IRB) (see 
Appendix H) approval was obtained before initiating the DNP project. Permission to use 
the MNSI tool was obtained (see Appendix I) prior to use. Permission to conduct the 
project  at the locations was also obtained (see Appendix J). There was minimal risk 
associated with this project. The patients who volunteered to participate were ensured 
their demographic data will be used only for the sake of the project. Informed consent 
was obtained prior to screening (see Appendix K). 
One benefit to the institutions was gaining a systematic approach to screen for 
(DPN). This project will assist in preventing unforeseen complications of T2DM. 
Patients will benefit from a screening that may assist in improving the quality and  length 
of life. The information received could be used to improve the quality-of-care patients 
receive at each location. The patient can have an increased sense of protection knowing 
their provider was allowing forward thinking research in their office. Patients who 




The MNSI tool improves the screening process of patients diagnosed with 
diabetes reporting signs and symptoms of DPN. Each of the facilities recognized the 
increase of patients identified early for DPN which improved quality care and adherence 
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to the gold standards of diabetes. Many of the participants reported contributing 
symptoms to their age not their diabetic diagnosis. The strength of this QI project is that 
it took minimum time for the patients and staff to complete, improved patient-provider 
trust, and has the potential to improved quality of life for the patient. The completion of 
the project sparked the interest of the staff and providers of surrounding healthcare 
facilities. This interest made the implementation of the project easy for those involved. 
The recommendation is to follow the model used in this project, screening with the 
MNSI tool during regularly scheduled visits. The MNSI tool has proven to be highly 
effective in recognizing early symptoms of DPN in patients who do not recognize 
common signs and symptoms. The wording of the tool was phrased in a way that patients 
of all educational levels understood the questions being asked in the tool. The use of this 
tool has the potential to save a significant amount of money for healthcare clinics, 
hospitals, and patients annually. It is recommended that further QI projects are 
preformed to increase the quality-of-care patients diagnosed with diabetes living in rural 
healthcare are receiving. This DNP project would benefit the inner cities, underserved, 
and lower income communities. 
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Identifying Number:    
 
Gender: M/F/T/A   
 
Age:    
 
Race or Self-Identified Cultural Background:    
 
Years of Diagnosis of Diabetes:    
 
Smoker: Y/N years smoked 
HTN: Y/N Hyperlipidemia: Y/N 
Podiatrist Y/N Last Visit 
Reason for today’s appointment   
 


























 mean sd 5.5% 94.5% 
B_VR_p 0.47 0.11 0.30 0.65 
W_VR_p 0.44 0.12 0.26 0.64 
Diff_VR_p 0.03 0.16 -0.23 0.29 
B_PR_p 0.82 0.09 0.67 0.93 
W_PR_p 0.79 0.10 0.61 0.92 
Diff_PR_p 0.03 0.13 -0.17 0.24 
 









 mean sd 5.5% 94.5% 
40s_VR_p 0.44 0.17 0.18 0.72 
50s_VR_p 0.50 0.21 0.16 0.84 
60s_VR_p 0.53 0.12 0.33 0.72 
70s_VR_p 0.39 0.13 0.20 0.61 
40s_PR_p 0.69 0.16 0.40 0.90 
50s_PR_p 0.50 0.21 0.16 0.84 
60s_PR_p 0.78 0.10 0.59 0.92 
70s_PR_p 0.88 0.09 0.71 0.97 
 



























 mean sd 5.5% 94.5% 
F_VR_p 0.34 0.10 0.19 0.51 
M_VR_p 0.64 0.12 0.43 0.82 
Diff_VR_p -0.30 0.16  -0.54 -0.03 
F_PR_p 0.84 0.08 0.69 0.94 
M_PR_p 0.77 0.11 0.57 0.91 
Diff_PR_p 0.07 0.13 -0.13 0.30 
 















 mean sd 5.5% 94.5% 
A_VR_p 0.35 0.09 0.21 0.51 
B_VR_p 0.75 0.13 0.50 0.92 
Diff_VR_p -0.40 0.16   -0.63 -0.12 
A_PR_p 0.83 0.07 0.70 0.93 
B_PR_p 0.75 0.13 0.50 0.92 
Diff_PR_p 0.08 0.15 -0.14 0.35 
 










DNP Project Timeline 
 


























Michigan Neuropathy Screening Instrument Consent 
 
RE: DNP student seeking permission to use MNSI tool 
Campbell, Pam <pamcamp@med.umich.edu> 
Sat 9/26/2020 7:37 AM 
To: 
 
• Kendra Ward Harris <kwardharris@stu.jsu.edu> 
 
Dear Ms. Harris, 
 
Please feel free to use our MNSI survey instrument. We just ask that you please cite our Center 
as follows: The project described was supported by Grant Number P30DK020572 (MDRC) from 






Michigan Diabetes Research Center 
Michigan Center for Diabetes Translational Research 
University of Michigan Medical School 
1000 Wall Street 
RM# 6100 Brehm Tower 




Remember to cite the Michigan Diabetes Research Center (MDRC) and/or the Michigan Center 
for Diabetes Translational Research (MCDTR) in publications: 
 
"The project described was supported by Grant Number P30DK020572 (MDRC) from the 
National Institute of Diabetes and Digestive and Kidney Diseases" OR the project described was 
supported by Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and 
















To Whom It May Concern: 
I, Kendra Ward Harris, MSN, RN, FNP-C, a Doctor of Nursing Practice (DNP) student at 
Jacksonville State University has permission to conduct a Quality Improvement DNP project 
titled: Preventing Complications of Undiagnosed Diabetic Peripheral Neuropathy in a Rural 























2055 East South Boulevard, Suite 908 
Montgomery, Alabama 36116 
(334) 284-6500 - Office 
(334) 284-6202 - Fax 
www.montgomeryvascular.com 
ROBERT E. ENGLES, JR., MD, FACS 
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To Whom It May Concern: 
 
 
I ,Kendra Ward Harris, MSN, RN, FNP-C, a Doctor of Nursing Practice (DNP) student at Jacksonville State 
University has permission to conduct a Quality Improvement DNP project titled: Preventing Complications of 
Undiagnosed Diabetic Peripheral Neuropathy in a Rural Healthcare Settings. This DNP project may be 
conducted at 2055 E South Blvd #908, Montgomery, AL 36116. 
 











CONSENT FOR PARTICIPATION IN A STUDY 
 
Title of Project: “Preventing Complications of Undiagnosed Diabetic Peripheral 
Neuropathy in Rural Healthcare Settings” 
Investigator Names: Kendra Ward Harris & Laura E. Barrow E-Mail Contact 
Information: kwardharris@stu.jsu.edu , lbarrow@jsu.edu 
 
You are being asked to participate in a research study. Before you give your consent to 
volunteer, it is important that you read the following information and ask as many 




Kendra Ward Harris, MSN, CRNP, FNP-C 
Laura E. Barrow, PhD, RN 
Purpose of the Research 
 
This project identifies patients with diabetes mellitus 2 who unknowingly suffer with 
diabetic peripheral neuropathy. Identifying the early onset of disease in a rural healthcare 
setting, during subsequent healthcare visits. The patients will become educated and 
referred to the proper specialist to slow the progression of the disease. The early 





If you volunteer to participate in this study, you will be asked to respond to questions 
asked in a semi-structured interview. Questions will be focused on personal symptoms 
you experience with diabetes mellitus 2. Your participation will consist of participating in 
one interview taking approximately 45 minutes. 
 
Potential Risks or Discomforts 
36 
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There are no foreseeable risks, however, participants may experience positive or negative 
feelings that may be experienced as they respond to questions or when reflecting onto the 
interview. The interview will be conducted at the patient’s regularly scheduled chronic 
care appointment. There are no costs associated with your participation in the study. You 
have the right to discontinue participation, temporarily or permanently, without any 
consequence. 
 
Potential Benefits of the Research 
 
There are personal benefits for patients participating in the study. The patients with 
participation will identify early signs diabetic peripheral neuropathy (DPN). The nursing 
profession and clinical practice standards will increase due to the knowledge obtained in 
this study. 
 
Confidentiality and Data Storage 
 
Identifying information will be confidential and not be shared with anyone. You will be 
asked to select a pseudonym, unrelated to your name, which will be used during your 
interview, on all transcriptions and notes and journaling, and your demographic 
datasheet. Your demographic datasheet will be kept in a locked location, separate from 
audio recordings and transcriptions. Your name will not be used in discussion with others 
regarding this research. If any identifying information is mentioned during your 
interview, that will be redacted from the written transcript and replaced with an 
alternative pseudonym. Other than any information that is redacted to protect the 
confidentiality, the interview will be transcribed verbatim. 
 
Data will be stored in the researchers’ offices on a password-protected computer. Only 
the researchers will have access to the surveys. Following the completion of the project, 
the surveys will be destroyed six months after the study. 
 
Questions, Participation, and Withdrawal 
 
Your participation in this research study is voluntary. As a participant, you may refuse to 
participate at any time. To withdraw from the study please contact the researchers at 334- 
333-6544, 256-490-3625, kwardharris@stu.jsu.edu , or lbarrow@jsu.edu. 
 
Reasons for Exclusion from this Study 
 
The exclusion criteria for this study include the inability to speak English or no diagnosis 













Signature of Person Obtaining Consent Date 
38 
